This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 801 of the RET protein (p.Leu801Phe). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RET-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
ClinVar Genomic variation as it relates to human health
NM_020975.6(RET):c.2401C>T (p.Leu801Phe)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(1)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
1
criteria provided, single submitter
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020975.6(RET):c.2401C>T (p.Leu801Phe)
Variation ID: 2134960 Accession: VCV002134960.2
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q11.21 10: 43119539 (GRCh38) [ NCBI UCSC ] 10: 43614987 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 8, 2023 Feb 20, 2024 May 7, 2022 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_020975.6:c.2401C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_066124.1:p.Leu801Phe missense NM_000323.2:c.2401C>T NP_000314.1:p.Leu801Phe missense NM_001355216.2:c.1639C>T NP_001342145.1:p.Leu547Phe missense NM_001406743.1:c.2401C>T NP_001393672.1:p.Leu801Phe missense NM_001406744.1:c.2401C>T NP_001393673.1:p.Leu801Phe missense NM_001406759.1:c.2401C>T NP_001393688.1:p.Leu801Phe missense NM_001406760.1:c.2401C>T NP_001393689.1:p.Leu801Phe missense NM_001406761.1:c.2272C>T NP_001393690.1:p.Leu758Phe missense NM_001406762.1:c.2272C>T NP_001393691.1:p.Leu758Phe missense NM_001406763.1:c.2266C>T NP_001393692.1:p.Leu756Phe missense NM_001406764.1:c.2272C>T NP_001393693.1:p.Leu758Phe missense NM_001406765.1:c.2266C>T NP_001393694.1:p.Leu756Phe missense NM_001406766.1:c.2113C>T NP_001393695.1:p.Leu705Phe missense NM_001406767.1:c.2113C>T NP_001393696.1:p.Leu705Phe missense NM_001406768.1:c.2137C>T NP_001393697.1:p.Leu713Phe missense NM_001406769.1:c.2005C>T NP_001393698.1:p.Leu669Phe missense NM_001406770.1:c.2113C>T NP_001393699.1:p.Leu705Phe missense NM_001406771.1:c.1963C>T NP_001393700.1:p.Leu655Phe missense NM_001406772.1:c.2005C>T NP_001393701.1:p.Leu669Phe missense NM_001406773.1:c.1963C>T NP_001393702.1:p.Leu655Phe missense NM_001406774.1:c.1876C>T NP_001393703.1:p.Leu626Phe missense NM_001406775.1:c.1675C>T NP_001393704.1:p.Leu559Phe missense NM_001406776.1:c.1675C>T NP_001393705.1:p.Leu559Phe missense NM_001406777.1:c.1675C>T NP_001393706.1:p.Leu559Phe missense NM_001406778.1:c.1675C>T NP_001393707.1:p.Leu559Phe missense NM_001406779.1:c.1504C>T NP_001393708.1:p.Leu502Phe missense NM_001406780.1:c.1504C>T NP_001393709.1:p.Leu502Phe missense NM_001406781.1:c.1504C>T NP_001393710.1:p.Leu502Phe missense NM_001406782.1:c.1504C>T NP_001393711.1:p.Leu502Phe missense NM_001406783.1:c.1375C>T NP_001393712.1:p.Leu459Phe missense NM_001406784.1:c.1411C>T NP_001393713.1:p.Leu471Phe missense NM_001406785.1:c.1384C>T NP_001393714.1:p.Leu462Phe missense NM_001406786.1:c.1375C>T NP_001393715.1:p.Leu459Phe missense NM_001406787.1:c.1369C>T NP_001393716.1:p.Leu457Phe missense NM_001406788.1:c.1216C>T NP_001393717.1:p.Leu406Phe missense NM_001406789.1:c.1216C>T NP_001393718.1:p.Leu406Phe missense NM_001406790.1:c.1216C>T NP_001393719.1:p.Leu406Phe missense NM_001406791.1:c.1096C>T NP_001393720.1:p.Leu366Phe missense NM_001406792.1:c.952C>T NP_001393721.1:p.Leu318Phe missense NM_001406793.1:c.952C>T NP_001393722.1:p.Leu318Phe missense NM_001406794.1:c.952C>T NP_001393723.1:p.Leu318Phe missense NM_020629.2:c.2401C>T NP_065680.1:p.Leu801Phe missense NM_020630.7:c.2401C>T NP_065681.1:p.Leu801Phe missense NC_000010.11:g.43119539C>T NC_000010.10:g.43614987C>T NG_007489.1:g.47471C>T LRG_518:g.47471C>T LRG_518t1:c.2401C>T LRG_518p1:p.Leu801Phe LRG_518t2:c.2401C>T LRG_518p2:p.Leu801Phe - Protein change
- L462F, L626F, L756F, L406F, L471F, L547F, L559F, L669F, L366F, L713F, L801F, L318F, L457F, L459F, L502F, L655F, L705F, L758F
- Other names
- -
- Canonical SPDI
- NC_000010.11:43119538:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| RET | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3595 | 3717 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
May 7, 2022 | RCV003048395.3 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(May 07, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia, type 2
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003347511.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 801 of the RET protein (p.Leu801Phe). … (more)
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 801 of the RET protein (p.Leu801Phe). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RET-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
Comment:
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 801 of the RET protein (p.Leu801Phe). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RET-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.